Format

Send to

Choose Destination
Front Biosci (Schol Ed). 2019 Mar 1;11:56-74.

----Delivery of siRNA therapeutics: PLGA nanoparticles approach.

Author information

1
Department of Sciences, Faculty of Natural and Applied Sciences, Notre Dame University - Louaize, Zouk Mosbeh, Lebanon Zouk Mikael.
2
Department of Sciences, Faculty of Natural and Applied Sciences, Notre Dame University - Louaize, Zouk Mosbeh, Lebanon Zouk Mikael, rita.maalouf@ndu.edu.lb.

Abstract

RNA interference is currently one of the most advanced genomic tools providing promising insight to manage countless pathophysiological conditions that seemed unapproachable few years ago. Researchers across the globe have devised numerous methods in which small RNA molecules can be administered into target cells to manipulate cellular functions at the molecular level and eradicate defects that lead to pronounced phenotypes, which might sometimes be as fatal as malignant tumors. The present review provides an overview of the non-viral delivery approaches for siRNA therapeutics with an emphasis on the PLGA polymeric strategy and its use in different biological applications. Due to its versatile surface, PLGA is not only used in tissue engineering such as remodeling of bone and cartilage, but it indeed plays a crucial role as chemical carrier for a broad range of therapeutic agents. It is greatly implicated in gene therapies and inherited genetic defects.

PMID:
30844736

Supplemental Content

Full text links

Icon for Frontiers in Bioscience
Loading ...
Support Center